, Volume 11, Issue 6, pp 451–460 | Cite as

Which Antirheumatic Drug?

  • F. Dudley Hart
Practical Theraputic


Successful therapy in a chronic rheumatic disease means choosing the right drug for the right patient with the right condition at the right time. In the treatment of gout three different types of treatment are given: for the acute episode, suppression and long-term therapy. Misuse of long-term therapy for acute gout will often aggravate the condition. As regards rheumatoid arthritis, in the absence of a known aetiology, treatment is essentially empirical and palliative; the use of milder well-tolerated anti-inflammatory agents for the less severe cases, more effective and more toxic agents for the more severe cases, and slow acting long-term agents for those not responding to previous measures is discussed. Night pain and morning stiffness has its own therapy. The place of corticosteroids throughout the whole field of rheumatology is evaluated. In the treatment of systemic lupus erythematosus corticosteroids still hold first place, but the cytotoxic (immunosuppressive) agents also play a part, though an arguable one.


Systemic Lupus Erythematosus Indomethacin Chloroquine Ketoprofen Divided Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Aylward, M.: Ginical studies on alclofenac in the treatment of rheumatic diseases. A drug in question. Current Medical Research and Opinion 3: 274 (1975)CrossRefGoogle Scholar
  2. Boardman, P.L. and Hart, F.D.: Indomethacin in the treatment of acute gout. Practitioner 194: 560 (1964).Google Scholar
  3. Decker, J.L.: Cytotoxic agents in the management of systemic lupus erythematosus. Clinics in Rheumatic diseases 1: 665 (1975).Google Scholar
  4. Hahn, B.H.; Kantor, O.S. and Osterland, C.K.: Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Annals of Internal Medicine 83: 597 (1975).PubMedGoogle Scholar
  5. Hart, F.D.: Inflammatory disease and its control in rheumatic diseases. British Medical Journal 4: 191 (1975).PubMedCrossRefGoogle Scholar
  6. Hill, H.F.H. and Hill, A.G.S.: Naproxen in ankylosing spondylitis. Scandinavian Journal of Rheumatology (Supplement 2): 121 (1973).Google Scholar
  7. Hunter, T.; Urowitz, M.B.; Gordon, D.A.; Smythe, H.A. and Ogryzlo, M.A.: Azathioprine in rheumatoid arthritis: A long term follow-up study. Arthritis and Rheumatism 18: 15 (1975).PubMedCrossRefGoogle Scholar
  8. Huskisson, E.C.: Rheumatology: Current concepts. In press (1975).Google Scholar
  9. Urowitz, M.B.: Immunosuppressive therapy in rheumatoid arthritis. The Journal of Rheumatology 1: 364 (1974).Google Scholar

Copyright information

© ADIS Press 1976

Authors and Affiliations

  • F. Dudley Hart
    • 1
  1. 1.Rheumatism ClinicWestminster HospitalLondonEngland

Personalised recommendations